NTLA

Intellia Therapeutics, Inc#82 · 2021EPB

Yearly return

+94%

Peak return

+232%

Max drawdown

-55%

ADR (20 days)

+7.8%

Base

24 days / -28.2%

Prior run

+59%

Breakout volume

16.0x

Pivot

$89.71

Analysten- oder Re-Rating-Impuls, oft mit Momentum-Folgekaeufern.

Healthcare · Healthcare & Biotech

Continue in the full Atlas

Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare NTLA with the current market directly.